Reliable studies indicate that one-third of COVID-19 patients experience neuropsychiatric symptoms, though more research is needed.
While the majority has fully recovered from the disease, a significant number of patients have reported neurological and psychiatric complications. Researchers have found that symptoms post-COVID-19 infection are common.
According to new research published in JAMA Psychiatry, short- and long-term neuropsychiatric symptoms were found in 20 to 70 percent of patients.
These included a range of symptoms like anosmia, brain fog, anxiety, depression, psychosis, seizures, and suicidal behavior. In addition, the study mentioned that short-term and long-lasting neuropsychiatric symptoms were more likely due to neuroinflammation and hypoxic injury. Researchers believe that viruses have the ability to damage the brain and affect its health.
Another retrospective study published in the Lancet also confirmed that around a third of patients with COVID-19 experienced such complications. The analysis was done for over a quarter of a million patients and found the correlation between COVID-19 and neurological disorders. Further, in patients admitted to intensive care, 46.42 percent of individuals were diagnosed with neurological or psychiatric disorders six months after the disease.
Though both these studies seem reliable, further research is required to corroborate the findings according to the study authors. Hence we have marked this as partly true.
The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19, including symptoms, prevention, and available treatment, please refer to the World Health Organization or your national healthcare authority.